Adaptive randomized study of idarubicin and cytarabine alone or with interleukin-11 as induction therapy in patients aged 50 or above with acute myeloid leukemia or high-risk myelodysplastic syndromes
Titel:
Adaptive randomized study of idarubicin and cytarabine alone or with interleukin-11 as induction therapy in patients aged 50 or above with acute myeloid leukemia or high-risk myelodysplastic syndromes
Auteur:
Giles, Francis J. Kantarjian, Hagop M. Cortes, Jorge E. Faderl, Stephan Verstovsek, Srdan Thomas, Deborah Garcia-Manero, Guillermo Wierda, William Ferrajoli, Alessandra Kornblau, Stephen Mattiuzzi, Gloria N. Tsimberidou, Apostolia M. Albitar, Maher O’Brien, Susan M. Estey, Elihu